Profile data is unavailable for this security.
About the company
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company. The Company is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.
- Revenue in USD (TTM)0.00
- Net income in USD-8.48m
- Incorporated2014
- Employees13.00
- LocationBiodexa Pharmaceuticals PLC1 Caspian Point, Caspian WayABINGDON CF10 4DQUnited KingdomGBR
- Phone+44 123 584 1575
- Websitehttps://www.biodexapharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Windtree Therapeutics Inc | 0.00 | -48.83m | 394.39k | 14.00 | -- | -- | -- | -- | -8.38 | -8.38 | 0.00 | -0.3449 | 0.00 | -- | -- | 0.00 | -172.27 | -48.72 | -791.65 | -52.57 | -- | -- | -- | -- | -- | -- | 22.36 | -- | -- | -- | 72.96 | -- | -42.51 | -- |
| Avenue Therapeutics Inc | 1.40m | -3.74m | 477.51k | 2.00 | -- | 0.1343 | -- | 0.3401 | -1.55 | -1.55 | 0.50 | 1.12 | 0.4422 | -- | -- | 702,000.00 | -119.06 | -159.81 | -122.59 | -215.40 | -- | -- | -269.23 | -- | -- | -- | 0.00 | -- | -- | -- | -12.29 | -- | -- | -- |
| Regenerative Medical Technology Grop Inc | 5.04m | -7.06m | 512.42k | 1.00 | -- | -- | -- | 0.1017 | -0.5629 | -0.5629 | 0.4019 | -2.40 | 1.30 | 24.95 | 69.50 | -- | -182.18 | -177.25 | -- | -- | 59.76 | 64.83 | -140.06 | -465.06 | 0.0784 | -0.0279 | -- | -- | 70.44 | 167.30 | 43.31 | -- | -- | -- |
| Bio Path Holdings Inc | 0.00 | -11.18m | 536.04k | 10.00 | -- | -- | -- | -- | -1.71 | -1.71 | 0.00 | -0.866 | 0.00 | -- | -- | 0.00 | -611.66 | -81.00 | -- | -90.58 | -- | -- | -- | -- | -- | -65.76 | -- | -- | -- | -- | 38.46 | -- | -- | -- |
| Longevity Health Holdings Inc | 1.46m | -5.74m | 545.07k | 15.00 | -- | -- | -- | 0.374 | -5.22 | -5.22 | 1.26 | -2.23 | 0.5077 | 1.11 | 47.31 | 97,153.34 | -199.84 | -- | -- | -- | 57.86 | -- | -393.63 | -- | 0.2676 | -- | -- | -- | -- | -- | 36.91 | -- | -- | -- |
| Novelstem International Corp | 3.00k | 2.31m | 562.58k | 15.00 | 0.2495 | -- | -- | 187.53 | 0.0481 | 0.0481 | 0.00006 | -0.0438 | 0.0281 | -- | 0.80 | -- | 630.69 | -- | -- | -- | -- | -- | 22,424.33 | -- | -- | -- | -- | -- | 0.00 | -- | 22.79 | -- | -- | -- |
| Helix BioMedix Inc | 2.07m | -2.58m | 609.46k | 8.00 | -- | 0.3887 | -- | 0.295 | -15.60 | -15.60 | 12.48 | 6.95 | 0.8047 | 1.87 | 4.55 | 258,238.80 | -100.64 | -146.31 | -120.73 | -173.57 | 68.96 | 30.80 | -125.06 | -527.12 | 1.69 | -14.57 | 0.00 | -- | 122.07 | 92.80 | 67.73 | -- | -29.08 | -- |
| Biodexa Pharmaceuticals PLC-ADR | 0.00 | -8.48m | 667.96k | 13.00 | -- | 0.0043 | -- | -- | -703.05 | -703.05 | 0.00 | 251.51 | 0.00 | -- | -- | 0.00 | -43.26 | -78.06 | -54.55 | -109.39 | -- | -- | -- | -2,404.45 | -- | -- | 0.042 | -- | -100.00 | -- | 19.07 | -- | 19.40 | -- |
| PMGC Holdings Inc | 285.95k | -4.48m | 696.95k | 2.00 | -- | 0.03 | -- | 2.44 | -57.57 | -129.01 | 3.93 | 45.64 | 0.0219 | 0.373 | 1.98 | 142,975.00 | -34.29 | -- | -48.32 | -- | 27.29 | -- | -1,567.42 | -- | 1.77 | -32.16 | 0.2734 | -- | -- | -- | -142.45 | -- | -- | -- |
| Hepion Pharmaceuticals Inc | 0.00 | -9.17m | 697.22k | 22.00 | -- | 0.4279 | -- | -- | -13.39 | -13.39 | 0.00 | 0.2861 | 0.00 | -- | -- | -- | -245.96 | -65.13 | -417.51 | -73.82 | -- | -- | -- | -- | -- | -5.25 | 0.0606 | -- | -- | -- | 73.04 | -- | -- | -- |
| CeCors Inc | -100.00bn | -100.00bn | 763.78k | 6.00 | -- | -- | -- | -- | -- | -- | -- | -0.0163 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 22.70 | -- | -- | -- |
| Protagenic Therapeutics Inc | -100.00bn | -100.00bn | 773.95k | 1.00 | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2945 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| CERo Therapeutics Holdings Inc | 0.00 | -49.19m | 835.39k | 8.00 | -- | -- | -- | -- | -175.56 | -175.56 | 0.00 | -3.04 | 0.00 | -- | -- | 0.00 | -282.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.12 | -- | -- | -- |
| Lipella Pharmaceuticals Inc | 389.79k | -5.33m | 887.20k | 5.00 | -- | 0.5964 | -- | 2.28 | -2.41 | -2.41 | 0.1286 | 0.3219 | 0.1729 | -- | 25.08 | 77,958.00 | -236.36 | -101.93 | -336.65 | -125.09 | -- | -- | -1,367.34 | -592.18 | -- | -- | 0.00 | -- | 19.29 | -5.04 | -8.60 | -- | -- | -- |
